News & Events :: RenovoRX, Inc. (RNXT)

Recent News View All News

May 28, 2026 8:30am EDT

RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer

May 26, 2026 8:30am EDT

RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting

Upcoming Events View IR Calendar

Jun 30, 2026 9:00 am PDT

2026 Annual Meeting of Stockholders

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Menu